Skip to content

Recall watch for the stuff you own · As an Amazon Associate we earn from qualifying purchases · Some links earn a commissionDisclosure

ConsumerSun

FDAFDA recall D-0166-2027 · Nov 11, 2026

Hikma Pharmaceuticals USA INC.: Ciprofloxacin Tablets recall

Quick answer

Product
Ciprofloxacin Tablets, USP, 750 mg, 50-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9929-50
Brand
Hikma Pharmaceuticals USA INC.
Codes, lots and dates
Lot# CA083A Exp. 12/31/2026 Lot# CA084A Exp. 12/31/2026 Lot# CA085A Exp. 12/31/2026
Hazard
CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
Distribution
US Nationwide
Quantity
20,335 bottles
Recall date
Nov 11, 2026
Agency
U.S. Food and Drug Administration (FDA) enforcement report
Recall number
D-0166-2027

Recall found

Product

Ciprofloxacin Tablets, USP, 750 mg, 50-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9929-50

Reason for recall

CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.

What to do

FDA enforcement reports don't include consumer instructions. Check the codes below against your packaging. If this is a medicine or device you use, talk to your pharmacist or doctor before you stop or change anything, and contact the company or FDA for what to do with the product.

Recall facts
Quantity20,335 bottles
Codes, lots and datesLot# CA083A Exp. 12/31/2026 Lot# CA084A Exp. 12/31/2026 Lot# CA085A Exp. 12/31/2026
DistributionUS Nationwide
Recall dateNov 11, 2026
ClassClass II
Agency IDD-0166-2027
Official noticeU.S. Food and Drug Administration (FDA) enforcement report
Data as of, last checkedNov 21, 2026, 3:48 PM EST

Recall details

FDA classification
Class II: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Status
Ongoing
Codes, lots and dates
Lot# CA083A Exp. 12/31/2026 Lot# CA084A Exp. 12/31/2026 Lot# CA085A Exp. 12/31/2026
Quantity
20,335 bottles
Distribution
US Nationwide
Recalling firm
Hikma Pharmaceuticals USA INC., Columbus, OH
Voluntary or mandated
Voluntary: Firm initiated
Recall started
2026-10-20

Source: openFDA enforcement record D-0166-2027 · search recall number D-0166-2027 in FDA's Enforcement Report.

Copied from the agency record without changes. Data as of Nov 21, 2026, 3:48 PM EST. The agency notice is the final word.

FAQ

What was recalled?

Product: Ciprofloxacin Tablets, USP, 750 mg, 50-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9929-50 Brand: Hikma Pharmaceuticals USA INC. Codes, lots and dates: Lot# CA083A Exp. 12/31/2026 Lot# CA084A Exp. 12/31/2026 Lot# CA085A Exp. 12/31/2026

What is the hazard?

CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.

How do I check if mine is affected?

Codes, lots and dates: Lot# CA083A Exp. 12/31/2026 Lot# CA084A Exp. 12/31/2026 Lot# CA085A Exp. 12/31/2026

Where was it distributed?

US Nationwide

Related recalls

Watch my items

Get an email when new recalls are posted for the kinds of things you own. Just your first name and email, nothing else.

Unsubscribe any time with one click. We never share your address.